Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy of Omnitrope in short children born small for gestational age
2006-002506-58Phase 4Completed
- Sponsor
- Sandoz
- Start
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of somatropin in Short stature in children born small for gestational age, sponsored by Sandoz. Primary endpoints: Development of diabetes during treatment and Incidence of anti-rhGH antibodies. Started Jun 2007; status: completed.
02
Drugs
somatropin
03
Conditions
Short stature in children born small for gestational age
Beyond the preview
Go deeper on 2006-002506-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002506-58.